Suchergebnis | Hamburg Open Science

Facetten

20 Einträge gefunden

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
2009 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
2006 - Forschungsinformationssystem des UKE
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of preoperative transition zone prostate cancer nomogram.
2006 - Forschungsinformationssystem des UKE
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
2006 - Forschungsinformationssystem des UKE
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
2004 - Forschungsinformationssystem des UKE
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
2003 - Forschungsinformationssystem des UKE
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
2002 - Forschungsinformationssystem des UKE
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
2002 - Forschungsinformationssystem des UKE
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
2002 - Forschungsinformationssystem des UKE
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
2002 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

Development and internal validation of preoperative transition zone prostate cancer nomogram.

Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.